feed,title,long_url,short_url
MedRxiv,"Safety and immunogenicity of the protein-based PHH-IV compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial",https://medrxiv.org/cgi/content/short/2022.07.05.22277210v1?rss=1,https://bit.ly/3nDhh3i
